High-dose Vorinostat effective at treating relapsed lymphomas, study suggests
Monday, February 4, 2013 - 15:30
in Health & Medicine
Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease.